Skip to main content
SpringerLink
Log in

Adalimumab/etanercept

Exacerbation of the interstitial lung disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rajapakse CN. Severe and rapid worsening interstitial lung disease in ra patients with introduction of a TNF inhibitor-two case reports. International Journal of Rheumatic Diseases 20 (Suppl. 1): 36 abstr. ABS108, Oct 2017. Available from: URL: http://doi.org/10.1111/1756-185X.13178 [abstract] - New Zealand

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/etanercept. Reactions Weekly 1679, 15 (2017). https://doi.org/10.1007/s40278-017-38740-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-38740-9

Search

Navigation